Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Review Article - (2014) Volume 5, Issue 3

Survivin as a Cancer Vaccine Target

Michael J Ciesielski1,2*, Jingxin Qiu3 and Robert A Fenstermaker1,4
1Department of Neurosurgery, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com
2Department of Immunology, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com
3Department of Pathology, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com
4Center for Immunotherapy, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com
*Corresponding Author: